Protective effects of Poria cocos and its components against cisplatin-induced intestinal injury
Ye-Ting Zou,Jing Zhou,Cheng-Ying Wu,Wei Zhang,Hong Shen,Jin-Di Xu,Ye-Qing Zhang,Fang Long,Song-Lin Li
DOI: https://doi.org/10.1016/j.jep.2020.113722
IF: 5.195
2021-04-01
Journal of Ethnopharmacology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p><em>Poria cocos</em> (Schw.) Wolf (Poria) is a well-known traditional medicinal fungus. It has been considered to possess spleen-invigorating (<em>Jianpi</em>) effects in traditional Chinese medicine, and is used clinically to treat spleen deficiency (<em>Pixu</em>) with symptoms of intestinal disorders such as diarrhea, indigestion, mucositis and weight loss.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">The aim of this study</h3><p>To investigate the protective effects of Poria and its three component fractions (Water-soluble polysaccharides, WP; alkali-soluble polysaccharides, AP; triterpene acids, TA) on cisplatin-induced intestinal injury and explore the underlying mechanisms.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>C57BL/6 mice were treated with Poria powder (PP), WP, AP and TA by oral gavage respectively for 13 days, and intraperitoneally injected with 10 mg/kg of cisplatin on day 10 to conduct a cisplatin-induced intestinal injury model. Pathological changes of ileum and colon were examined using H&E staining. The composition of gut microbiota and the alteration of host metabolites were characterized by 16S rDNA amplicon sequencing and UPLC-QTOF-MS/MS based untargeted metabolomics analysis.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>PP and WP attenuated the cisplatin-induced ileum and colon injury, and WP alleviated the weight loss and reversed the elevation of IL-2, IL-6 in serum. Both PP and WP could mitigate cisplatin-induced dysbiosis of gut microbiota, in particular PP and WP decreased the abundance of pathogenic bacteria including <em>Proteobacteria</em>, <em>Cyanobacteria</em>, <em>Ruminococcaceae</em> and <em>Helicobacteraceae</em>, while WP promoted the abundance of probiotics, such as <em>Erysipelotrichaceae</em> and <em>Prevotellaceae</em>. Moreover, WP attenuated the cisplatin-induced alteration of metabolic profiles. The levels of potential biomarkers, including xanthine, L-tyrosine, uridine, hypoxanthine, butyrylcarnitine, lysoPC (18:0), linoleic acid, (<em>R</em>)-3-hydroxybutyric acid, D-ribose, thiamine monophosphate, indolelactic acid and plamitic acid, showed significant correlations with intestinal flora.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>PP and WP possess protective effects against cisplatin-induced intestinal injury <em>via</em> potentially regulating the gut microbiota and metabolic profiles.</p>
pharmacology & pharmacy,chemistry, medicinal,integrative & complementary medicine,plant sciences